A new study by researchers from the University hospital århus in Denmark discovered that aspirin or some other pain relievers can protect against the development of skin cancer.
Research on the impact of nonsteroidal anti-inflammatory drugs, including aspirin, ibuprofen, the risk of developing some cancers have been already accomplished. For example, it has been proven that a daily dose of aspirin reduces the risk of cancer in middle-aged people from the risk group. Or that in colon cancer, a daily dose of aspirin significantly prolongs life, as found by researchers from Leiden University Medical Centre in the Netherlands.
The new study, led by Dr. Sigrun Alba Johannesdottir tried the effect of antiinflammatory drugs on three types of skin cancer: malignant melanoma, squamous carcinoma cells and carcinoma of the lower cells. Melanoma is the most dangerous type of skin cancer that are quickly spreading to other parts of the body, it is the cause of death number one among the skin diseases.
The study was conducted by analysis of medical records of patients seen in Denmark from 1991 to 2009. The results of the analysis of their medical prescriptions showed:
- High intensity taking anti-inflammatory drugs for seven years had the greatest preventive effect against skin cancer.
- People who took at least two non-steroidal anti-inflammatory drug, 15 percent less developed skin cancer.
- On the risk of developing carcinoma of the lower cells, the most common type of skin cancer, accounting for 75 percent of all skin cancer diseases, aspirin, however, no influence.
"Now, when doctors will talk about the harms and benefits of anti-inflammatory drugs, they should take into account the preventive effect of these drugs against the development of skin cancer patients," said study author Dr. Johannesdottir.